Singular Genomics' shares surged 61% after receiving acquisition proposals from Concentra Biosciences, Tang Capital, and Deerfield Management. The company stated that there is no guarantee the transactions will be finalized, regardless of the party involved.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing